All Q2 FY27 results →
CC

Chembond Chemic.

Q2 FY27Chemicals & Petrochemicals

Chembond Chemicals Q2 Results 2026 (FY27): Revenue ₹182.25 Cr

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹229
Market cap₹615 Cr
P/E16.1
Updated24 Oct 2026
Read2 min read

Based on Chembond Chemic.'s Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Revenue: - HY1 2026-27 consolidated revenue: ₹182.25 crores, a 32% increase vs HY1 2025-26 (Page 20, 23) - EBITDA for HY1 2026-27: ₹22.55 crores, a 2% increase vs HY1 2025-26 (Page 20) - Profit Before Tax (PBT) for HY1 2026-27: ₹19.79 crores, a 2% increase vs HY1 2025-26 (Page 20)

From Chembond Chemic.'s Q2 FY27 earnings-call transcript · updated 24 Oct 2026.

Revenue & Sales Performance

  • Revenue:
  • HY1 2026-27 consolidated revenue: ₹182.25 crores, a 32% increase vs HY1 2025-26 (Page 20, 23)
  • Sales Volume:
  • Sales Growth:
  • 32% sales growth reported (Page 23).
  • Revenue Outlook:
  • Revenue outlook remains positive across all business units (Page 20).

2 more points from Chembond Chemic.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Chembond Chemic. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

See what Chembond Chemic. said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chembond Chemic. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The investor presentation reports a 28% order book growth momentum specifically in the Water Technologies segment (Page 20, H1 Executive Commentary).
  • The focus is on growth momentum rather than absolute order book numbers or pending order details.

Chembond Chemic. — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹96 Cr, net profit ₹3 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Chembond Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

  • NOCIL Ltd (Q2 FY27)

    427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

  • Neochem Bio Solutions Ltd (Q2 FY27)

    Revenue from Operations for H1 FY27: ₹68.9 crores, up 50% YoY (from ₹45.8 crores in H1 FY26) [Page 22] . Key investor presentation takeaways from Neochem Bio So

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Chembond Chemic. and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Chembond Chemic. Q2 FY27 results?

Revenue: - HY1 2026-27 consolidated revenue: ₹182.25 crores, a 32% increase vs HY1 2025-26 (Page 20, 23) - EBITDA for HY1 2026-27: ₹22.55 crores, a 2% increase vs HY1 2025-26 (Page 20) - Profit Before Tax (PBT) for HY1 2026-27: ₹19.79 crores, a 2% increase vs HY1 2025-26 (Page 20)

What is Chembond Chemic. share price analysis?

Chembond Chemic. currently shows a neutral. The stock trades at a P/E of 16.1 with a market cap of ₹615 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Chembond Chemic. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.